Katrina M Johnson, CTRS, MSW,LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 210 Airport Road, Suite 103, Viroqua, WI 54665 Phone: 608-638-7420 |
Mr. Kevin Richard Schmidt, MSSW. LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 407 S Main St, Viroqua, WI 54665 Phone: 608-637-3195 |
Kelsey R Thompson, QTT Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1321 N Main St, Viroqua, WI 54665 Phone: 608-637-7052 |
Cheryl L. Hagerman, MSSW, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1321 N Main St, Viroqua, WI 54665 Phone: 608-637-7052 Fax: 608-637-8500 |
Donna M. Jolley, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1321 N Main St, Viroqua, WI 54665 Phone: 608-637-7052 Fax: 608-637-8500 |
Paul P Schmidt, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 407 S Main St, Viroqua, WI 54665 Phone: 608-637-3195 |
Kathryn M Frydenlund, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 122 W South St, Viroqua, WI 54665 Phone: 608-637-2511 Fax: 608-637-7921 |
Ms. Susan Kopp Townsley, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 414 S East Ave, Viroqua, WI 54665 Phone: 608-638-3332 Fax: 608-637-7328 |
News Archive
Quintiles' digital efforts to bridge the gaps between clinical research, patients and clinical trial participants have been recognized in the form of two International Davey Awards and a Web Health Award this week.
The World Allergy Organization (WAO) will publish its first Report on the extent of allergy and chronic respiratory diseases worldwide on the 18 June 2008 and has called for immediate collaboration to tackle the current escalation in allergy cases.
Scientists still do not know what causes epileptic seizures, but researchers from Melbourne's Howard Florey Institute are one step closer to solving this puzzle with the help of their newly developed genetically modified epileptic mouse.
ISTA Pharmaceuticals, Inc., today announced it has initiated a Phase 2 clinical study of bepotastine besilate nasal spray for the treatment of symptoms associated with seasonal allergic rhinitis, the inflammation of the nasal passages caused by allergies. The randomized, placebo-controlled, parallel-group environmental study will evaluate the safety and efficacy of bepotastine besilate, dosed twice daily, in patients presenting with allergic rhinitis caused by one of the most potent seasonal allergy triggers, Mountain Cedar pollen.
More than 1,100 women are raped every day in the Democratic Republic of the Congo (DRC), according to a study published on Tuesday in the June issue of the American Journal of Public Health, Agence France-Presse reports.
› Verified 8 days ago